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Quantification of nanoparticle uptake into cells provides important information for both the 26 
assessment of novel nanomedicines and for nanosafety studies. Among several methods available 27 
to detect and/or quantify nanoparticle uptake, flow cytometry represents a robust high throughput 28 
method that allows measuring the internalisation of fluorescently labelled nanoparticles in 29 
thousands of individual cells in relatively short time. Several factors can influence and affect 30 
studies of nanoparticle uptake into cells, from the quality of the label and its stability, to the 31 
preparation of the nanoparticle dispersion, the way cells are exposed to the nanoparticles and 32 
several steps of sample preparation for flow cytometry measurement. Here we discuss the impact 33 
of all of these factors and methods to take them into account in order to avoid artefacts in the 34 
quantification of nanoparticle uptake and to ensure reproducibility. We then present a Standard 35 
Operating Procedure (SOP) for the quantification of nanoparticle uptake by flow cytometry, 36 
which has been developed within the European Research Infrastructure QualityNano by taking 37 
into account all of the described factors. Finally, we show the results obtained using the 38 
QualityNano SOP, demonstrating that with this SOP very good agreement in nanoparticle uptake 39 
measurements is achieved in independent laboratories by different operators using different 40 
instruments. 41 
 42 
Keywords: nanoparticle uptake, flow cytometry, fluorescently labelled nanoparticles. 43 
 44 
1. Introduction 45 
Research on the biological interactions of nanomaterials has seen an enormous growth in the last 46 
decades as the potential of nanoparticles in different areas of applications such as medicine
1, 2
 or 47 
different kind of products has become clear and therefore concerns on the safety of 48 
nanotechnology have to be adressed.
3, 4
 One of the crucial issues for both their application in 49 
nanomedicine and for the assessment of their potential toxicity is whether nanoparticles enter 50 
cells. It is furthermore important to quantify the internalised amount as it allows distinguishing 51 
the applied dose from the internalised dose into cells or organisms. This is essential information 52 
since the internalised amount, rather than the applied dose, is often responsible for the biological 53 
action of nanoparticles.
5
 In some cases it may even be the sub-cellular dose in specific cellular 54 
compartments that determines certain biological responses, and ideally one would like to be able 55 
to determine the internalised dose with the necessary resolution.
6
 By quantifying the internalised 56 
dose and following the uptake process over time, the full life-cycle of nanoparticles inside cells 57 
can be studied. Thereby it is possible to determine uptake kinetics, and monitor saturation or 58 
competing processes such as nanoparticle export, nanoparticle degradation and cell division.
7-10
 59 
Different methods are available to determine nanoparticle uptake: in some cases these take 60 
advantage of a distinguishable nanoparticle chemical composition compared to the organic 61 
components of cells. For instance, metal and metal oxide nanoparticles can be easily quantified 62 
by classic analytical methods, such as inductively coupled plasma mass spectrometry (ICP-MS) 63 
or atomic emission spectroscopy (ICP-AES).
11-14
 Typically, in standard measurement mode of 64 
ICP based techniques the total amount of a given element is obtained. Thus, for partially soluble 65 
nanoparticles, released ions, fragments of nanoparticles and the actual nanoparticles are 66 
indistinguishable. Furthermore, these methods are typically used to quantify uptake in 67 
populations of cells rather than in single cells.  However, recent advancements in these 68 
techniques allow distinguishing ions from nanoparticles
15
 and also to perform measurements in 69 
single cells.
16, 17
 The major disadvantage of ICP based techniques is that the sample is destroyed 70 
by the measurement, thus prohibiting the possibility for further analysis. Non-destructive 71 
elemental analysis methods include Particle-Induced X-ray Emission (PIXE). PIXE can only 72 
determine the total elemental amount, and not the amount in nanoparticle form
18, 19
 and can also 73 
be used for quantification at a single cell level. Currently, these latter methods are available 74 
mostly in specialised laboratories. 75 
Other methods allow detection of nanoparticles by taking advantage of specific intrinsic 76 
properties of the nanomaterial. For example, the capacity of many nanoparticles to reflect light 77 
can be used to advantage to visualise and – to some extent – quantify their presence inside 78 
cells.
20, 21
 Another example is the detection of magnetic nanoparticles using magnetic 79 
resonance.
22
 Furthermore, some nanomaterials, such has carbon nanotubes, exhibit a 80 
characteristic Raman signal. Raman signals are easy to distinguish from the cell background and 81 
can be used to detect such nanomaterials inside cells.
23
 Other optical properties exploited for 82 
imaging and detection of nanoparticles include surface plasmon resonance (e.g., for gold),
24, 25
 83 
and intrinsic luminescence (e.g., for ultra-small silica nanoparticles).
26
 More recently second 84 
order harmonic generation and upconversion,
27
  among other techniques, are also being exploited. 85 
All these methods are useful to detect nanoparticles and thus to confirm uptake. However, they 86 
do not allow quantification of the internalised amount. 87 
For polymeric and carbon-based nanoparticles and, in general, nanoparticles, which are more 88 
difficult to distinguish from the cell background, additional labelling is often required. Included 89 
among these particles are lipid-based nanovectors, such as liposomes,
28
 or protein-based 90 
nanoparticles, such as albumin nanoparticles.
29
 Stable isotope, radioactive isotope, and 91 
fluorescence labelling are among the most common forms of labelling.
30
 Labelling opens up 92 
other possibilities to visualise and quantify nanoparticles in biological matrices and study their 93 
interactions with organisms and cells. Fluorescence labelling, for instance, allows monitoring 94 
nanoparticle uptake in living cells in real time.
31
 It also provides a means to quantify 95 
nanoparticles inside cells, as the fluorescence of cells after nanoparticle uptake can be measured. 96 
The addition of a label to a nanoparticle may, however, also introduce some issues: surface 97 
labelling can, for instance, alter the interaction of the nanoparticle with the surrounding 98 
environment, as it de facto creates a different surface compared to the unlabelled material. This 99 
should be kept in mind when one aims to study the behaviour of the pristine material, rather than 100 
that of its (altered) surface labelled variant (Further studies may help to fully demonstrate 101 
eventual impact of the surface modification on the interaction with the environment, such as for 102 
instance an analysis of the protein corona composition for the pristine and surface labelled 103 
material). In this case, strategies for internal labelling (if available) may be preferred, thereby 104 
keeping the original surface unaltered, or at least less changed. Furthermore, the stability of the 105 
label in/within the nanoparticle needs to be determined and unreacted label needs to be removed 106 
very carefully to ensure that only the label bound to the nanoparticle is quantified.
32, 33
 The 107 
presence of free or labile dyes can in fact lead to misinterpretation in quantifying the nanoparticle 108 
signal.
8
 This particular issue will be discussed more in detail in the following, and examples on 109 
how to detect and discriminate signals from free dyes as opposed to nanoparticle-bound labels 110 
will be shown. 111 
Each of the mentioned methods for uptake quantification has advantages and limits. For instance, 112 
in many cases measurements are performed on cell populations rather than in single cells. 113 
Frequently, signals can be detected, but absolute quantification is not possible unless some form 114 
of calibration is performed. Some of the methods are rather time-consuming and not yet available 115 
in common laboratories. Another common limitation is that in many cases it is difficult or not 116 
possible to distinguish particles adhering to the cell membrane from those genuinely internalised. 117 
In general, when possible, the combination of multiple approaches for nanoparticle uptake is 118 
always beneficial. 119 
Within this context, flow cytometry is a robust method that yields quantitative data of 120 
fluorescently labelled nanoparticle uptake into cells, and which is commonly available in most 121 
biological laboratories. Flow cytometry can be used to measure nanoparticle accumulation in 122 
individual cells. Tens of thousands of cells per sample can be readily measured in a short time, 123 
obtaining important information also on the variability of the response within a cell population. 124 
Although absolute nanoparticle numbers can only be determined upon careful calibration of the 125 
fluorescence signal, relative measurements can easily be performed to compare samples and 126 
determine dose-response curves or uptake kinetics.
7, 8
 127 
Extensive work has been performed in the last few years to quantify nanoparticle uptake by this 128 
method. Here we summarise the practical principles of flow cytometry, and we illustrate how 129 
flow cytometry can be used for nanoparticle uptake studies. We also provide extensive details on 130 
how to address and overcome potential limits of this method. We then show how flow cytometry 131 
can be used for testing for possible contamination of free label. This and other several examples 132 
of factors that affect this kind of measurement, which could lead to mistakes if not recognised, 133 
are presented. Finally, we present data generated in three different laboratories using a Standard 134 
Operating Procedure (SOP) which has been developed within the European Research 135 
Infrastructure QualityNano. For this purpose, we have chosen carboxylated polystyrene as a 136 
model nanoparticle, already well characterised and easy to disperse also in cell culture medium 137 
containing serum.
7
 The SOP has been developed taking into account all of the factors mentioned. 138 
The results generated using this SOP demonstrate that independent laboratories can now obtain 139 
highly reproducible data on nanoparticle uptake, as required to ensure quality in nanosafety 140 
testing. The SOP and approaches presented can be easily adapted to other nanoparticles and cells, 141 
as indeed has already been done for instance for silica nanoparticles.
35
 Overall, provided care is 142 
taken in order to control and exclude a series of potential sources of artefacts and variability 143 
(discussed more below), flow cytometry is well suited to generate robust data on nanoparticle 144 
uptake by cells.  145 
 146 
2. Results and Discussion 147 
2.1. Practical principles of flow cytometry 148 
Flow cytometry is a fluorescence-based method in which a suspension of cells (or other small 149 
objects, such as microorganisms, cellular fragments or particles) is passed across one or several 150 
lasers, in such a way that only one cell faces the laser at a defined time.
34
 As each individual cell 151 
passes in front of the lasers, the light scattered by the cell in the forward and side directions is 152 
detected, together with the fluorescence signal emitted by the fluorescent species (here: 153 
nanoparticles) present in the illuminated volume. Multiple fluorophores can be detected 154 
simultaneously using different filters and laser combinations, with some instruments nowadays 155 
allowing the quantification of up to eighteen different parameters per cell. Furthermore, forward 156 
and side scattering (FS and SS, respectively), which are recorded simultaneously, provide 157 
information on the size and internal density or granularity of the objects illuminated by the lasers. 158 
Variations in the FS/SS double scatter plots in the presence of a biological response or due to cell 159 
damage yield additional information on the health of the cell population and of individual cells. 160 
Typically, 10-50k individual cells are measured for each sample at speeds between 300-1000 161 
events/s, with all of the parameters mentioned determined for each individual cell. This clearly 162 
illustrates how large amounts of quantitative data can be recorded easily and in short time. 163 
Appropriate gates can be set in order to exclude the signal generated by cell debris, which 164 
exhibits much smaller FS and SS as shown in Figure 1, or to select sub-populations of cells for 165 
separate analysis. It is important to stress that this method allows quantifying (in this case) 166 
nanoparticle uptake for individual cells, as opposed to many other methods where only a single 167 
value for the full population of cells may be measured. In this way, important information on the 168 
response of individual cells and on the variability within cell populations can also be obtained. 169 
For instance, it has been shown that within a cell population nanoparticle accumulation is 170 




2.2. Flow cytometry to measure uptake of nanoparticles into cells 173 
An example of a typical FS-SS double scatter plot together with the fluorescence intensity 174 
distribution of cells exposed to fluorescently labelled nanoparticles is given in Figure 1. After 175 
exposure to fluorescently labelled nanoparticles, the distribution of cell fluorescence shifts to 176 
higher values as a consequence of the cells taking up nanoparticles. In many cases, as shown 177 
here, a relatively narrow distribution is obtained; however, also in this case it is evident that cells 178 
within the population have internalised varying amounts of nanoparticles (note the logarithmic 179 
scale in Figure 1C-D). 180 
Applied dose-internalised dose curves (the internalised dose being the “response” in a dose-181 
response curve) can be generated by exposing cells to different doses of nanoparticles for a given 182 
fixed time. Similarly, by measuring multiple samples at different exposure times, uptake kinetics 183 
can be obtained. For instance, this approach can address whether uptake saturates or competing 184 
processes, such as export, degradation or cell division are present.
7, 35
 Changes in the shape of the 185 
fluorescence distribution, such as the appearance of multiple peaks, can also be monitored and 186 
are signs of variability in the response of the cells to the nanoparticles. Moreover, as mentioned 187 
earlier, changes in the FS-SS plots are indicative of cellular stress and cell damage. Other 188 
fluorescent probes can be added and measured at the same time using appropriate lasers and 189 
filters in order to combine the quantification of nanoparticle uptake with other parameters. For 190 
instance, the total DNA and DNA synthesis can be simultaneously monitored with appropriate 191 
markers. Thereby, cells in different phases of the cell cycle can be distinguished and the uptake 192 




Figure 1. Typical flow cytometry results for untreated cells (left) and cells exposed to 195 
fluorescently labelled nanoparticles (right). A549 lung epithelial carcinoma cells were exposed 196 
to 100 µg/ml Yellow-Green 40 nm carboxylated polystyrene nanoparticles for 24 h. (A) and (B) 197 
Double scatter plots of side scattering (SS Linear) versus forward scattering (FS Linear) of 198 
untreated cells (A) and cells exposed to 100 µg/ml Yellow-Green 40 nm carboxylated 199 
polystyrene nanoparticles for 24 h. Healthy cells (within the A rectangle) can be easily 200 
distinguished from cell debris (outside the A rectangle) which typically has much lower FS and 201 
SS signals. In the example this is done by applying the gate A. (C) and (D) Green cell 202 
fluorescence intensity distributions (signal collected in the FL1 channel) in logarithmic scale. 203 
Untreated cells (C) have a low background fluorescence signal, while cells exposed to 100 µg/ml 204 
Yellow-Green carboxylated polystyrene nanoparticles (D) exhibit much higher fluorescence 205 
intensity due to particle uptake.  206 
 207 
Interestingly, some nanomaterials scatter light rather strongly and for such materials flow 208 
cytometry allows the quantification of nanoparticle uptake by detecting changes in side 209 
scattering. This effect is slightly discernible in Figure 1, although in this case it is rather small for 210 
the polystyrene nanoparticles used there. However, for other materials, such as metal and metal 211 
oxide nanoparticles, the effect can be much stronger.
36
 An example of this is shown in Figure 2, 212 
which presents results for cells exposed to titanium dioxide nanoparticles. The results clearly 213 
show that the side scattering distributions shift to higher values at increasing exposure times, 214 
consistent with a higher number of titanium dioxide nanoparticles in the cells. In performing such 215 
measurements, care has to be taken to ensure that the increased cell side scattering is, indeed, due 216 
to nanoparticles, and not due to cell damage (since cell damage often leads to cell death, a cell 217 
viability test can help ruling this out). Side scattering will also be very much influenced by the 218 
chemical nature of the scattering nanoparticles and their state of agglomeration. Exercising 219 
caution, changes in side scattering can thus also be used as a measurement of nanoparticle uptake 220 
for unlabelled nanoparticles, albeit with a much lower sensitivity compared to fluorescently 221 
labelled ones.  222 
 223 
 224 
Figure 2. Measuring nanoparticle uptake by changes in cell side scattering. A549 lung 225 
epithelial carcinoma cells were exposed to 10 μg/ml carboxylated TiO2 nanoparticles for the 226 
indicated times prior to measurement of side-scattering (SS Area) by flow cytometry. Control 227 
refers to untreated cells not exposed to nanoparticles. 228 
 229 
2.3. Limits and issues of flow cytometry measurements for nanoparticle uptake 230 
Several issues need to be taken into consideration when using flow cytometry to measure 231 
nanoparticle uptake in order to avoid creating artefacts or misinterpreting results. We will 232 
illustrate these issues for every aspect, from sample preparation to measurement. 233 
First of all, it is essential to test both the quality of the nanoparticle labelling and the stability of 234 
the label over time. Residual free or labile dye can strongly affect the measurements of 235 
nanoparticle uptake,
8, 32
 because the free dye can enter and leave the cell much more rapidly than 236 
nanoparticles, thus obscuring the signal. Even when the dye is chemically bound to the 237 
nanoparticles, residual unreacted label from the synthesis needs to be removed and can be 238 
difficult to wash off from high energy nanoparticle surfaces. Both electrostatic interactions and pi 239 
stacking can lead to strong adsorption of dyes to the surface of nanoparticles without the dye 240 
being covalently linked. Hence, standard cleaning procedures such as dialysis or centrifugation 241 
can be less effective and in need of optimisation when applied to nanoparticles.
32
 Dyes adsorbed, 242 
but not covalently bound, to nanoparticles can detach once the nanoparticles are dispersed in 243 
biological fluids or inside cells, yielding false information on the location and quantity of the 244 
nanoparticle. Moreover, nanoparticle degradation in biological fluids may lead to release of dye 245 
as it has been shown – for instance - for silica nanoparticles.
33
 246 
Size exclusion gel electrophoresis such as used by Salvati et al.
8
 and shown in Figure 3A can be 247 
used to test for the presence of free or labile dye in the nanoparticles prior to their use: while 248 
nanoparticles typically are too large, free dye and fragments of nanoparticles can enter the gel. A 249 
fluorescence image reveals the presence of contaminants, separated according to their size. 250 
Furthermore, the kinetics of cellular uptake of small hydrophobic dyes differs strongly from that 251 
observed for nanoparticles: small dyes can easily enter and leave cells by passive diffusion. On 252 
the contrary, nanoparticle uptake is energy dependent and export is in most cases absent.
7, 8
 253 
Kinetic experiments by flow cytometry, such as those shown in Figure 3B-C, can thus be used to 254 




Figure 3. Issues of free dye contamination in labelled nanoparticle samples. (A) Fluorescence 257 
images of SDS-PAGE gels can be used to detect the presence of residual free dye or degradation 258 
in nanoparticle dispersions. Size exclusion allows separating the nanoparticles (on the top of the 259 
gel, lanes 2-4) from smaller fragments (visible in the upper part of the gel in lanes 2 and 3) or 260 
labile dye (on the bottom, lanes 1-4). Lane 1 contains free dye only. (B) and (C) Flow cytometry 261 
can be used to detect the presence of residual free dye in nanoparticle samples. Kinetics and 262 
energy dependence of uptake of nanoparticles (B) and free dye (C), respectively, by A549 cells. 263 
Under energy depleted conditions (NaN3) and at lower temperature, active processes of 264 
nanoparticle uptake are inhibited (B). In contrast, free dyes can still enter cells by passive 265 




Besides issues related to the labelling of nanoparticles, cell related issues can also affect 268 
nanoparticle uptake experiments. Known examples are cell cycle and cell density. As a 269 
consequence of cell division, in which the internalised nanoparticle load becomes distributed 270 
among the daughter cells, cells in different phases of the cell cycle show different amounts of 271 
internalised nanoparticles.
7, 10
 Thus, for comparability, experiments should be performed keeping 272 
constant the fraction of cells in each cell cycle phase. Asynchronous cell populations typically 273 
have well defined proportions of cells in the different cell cycle phases. However, cell density 274 
and cell confluence are known to affect these proportions and thus should be taken into account. 275 
As an example, Supplementary Figure S1 shows nanoparticle uptake results for cells seeded at 276 
different starting densities. The different populations were exposed to the same nanoparticle 277 
dispersions 24 h after plating. The spread of the data indicates that cell density affects 278 
nanoparticle uptake. Another important factor is the time that cell cultures have been grown on 279 
the plate before the experiment and also the passage number since the cells were brought into 280 
culture. Typically, cell cultures are grown from frozen stocks within a certain range of passages, 281 
the optimal range of which varies depending on the cell line. It is known that the behaviour of the 282 
cells can change drastically with passage number due to differentiation events or accumulation of 283 
chromosome aberrations and spontaneous mutations that they undergo while in culture. Hence, 284 
for nanoparticle uptake studies it is important to use cells of the appropriate passage numbers. 285 
Consequently, when comparing results obtained in different experiments, passage numbers 286 
should be noted since differing numbers could be a source of variability in the outcomes. 287 
A more general and crucial issue in experiments using nanoparticles is the preparation of the 288 
nanoparticle dispersions and their application to cells. Different nanoparticles may require 289 
different procedures to ensure that optimal dispersions are obtained. Here we want to stress that 290 
careful characterisation of the starting dispersion in cell culture media (or the media used for the 291 
study) and its stability for the duration of the experiment should be performed in order to ensure 292 
that comparable dispersions are obtained and exposed to cells each time.
37-39
 If not controlled, 293 
different qualities of dispersion can lead to very different outcomes in independent experiments. 294 
Moreover, in many cases nanoparticle dispersions can age with time, including for example 295 
changes in the nanoparticle surface redox potential, surface adsorption of molecular species from 296 
the environment, bleaching of fluorescent labels etc., and the time between the preparation of the 297 
dispersion and the exposure to cells should be kept constant, as much as possible. Other factors to 298 
keep in mind – and control – are the order of mixing used to dilute nanoparticle stocks into the 299 
medium used for the experiment, since it could lead to different dispersions; the temperature of 300 
the medium used to prepare the dispersion; and the volume of dispersion added to cells. The last 301 
parameter is often not reported in literature, but needs to be specified and should be kept 302 
sufficiently high in order to exclude nanoparticle depletion in the extracellular medium due to 303 
cell uptake. Moreover, the way the dispersion is added to cells matters. Replacing the medium 304 
with the nanoparticle dispersion already prepared at the required dose seems to be preferable, 305 
while adding a small volume of nanoparticles at a high dose directly into the dish impairs proper 306 
mixing and often results in agglomeration and non-uniform exposure of the nanoparticles to the 307 
cells. This, in turn, may lead to differing uptake within the cell population, especially for short 308 
exposure times. 309 
The medium used to prepare the dispersion also needs to be specified. First, it is imperative to 310 
use medium supplemented with serum or other biomolecules. It is known that once in contact 311 
with serum or other biofluids, a layer of biomolecules adsorb on the nanoparticle surface, 312 
forming a so-called biomolecular corona on the nanoparticles
40-42
. In the absence of a corona, 313 
nanoparticles typically interact strongly with the cell membrane,
43
 in some cases killing the cell 314 
in the process.
44
 Such effects are unlikely to ever occur in vivo because nanoparticles will always 315 
interact with cells in the presence of biomolecules. This is avoided by “passivating” the surface 316 
using supplemented biomolecules, thus creating a more realistic scenario. Second, the type of 317 
biomolecules used to supplement the cell culture medium needs to be specified, since it will 318 
change the composition of the corona on the nanoparticles. Different batches of serum, as a 319 
typical media supplement, can, in fact, lead to different levels of uptake, even for the same cells 320 
and nanoparticles, because the protein composition differs. Procedures such as heat inactivation, 321 
which also alter the serum composition, can introduce further differences if not controlled.
45
 322 
Similarly, the concentration of proteins added needs to be kept constant, since it has been 323 
demonstrated that varying the protein concentration in the medium results in very different levels 324 
of uptake.
44, 46
 Finally, the type of cell culture medium also needs to be specified, because it has 325 




After exposure to nanoparticles, the next important aspects to take into consideration are those 328 
related to sample preparation for measurement. The first of these steps is the removal of the 329 
extracellular medium containing the nanoparticles prior to measurement. It is important to 330 
carefully remove all remaining extracellular nanoparticles by washing. Flow cytometry detects 331 
the fluorescence in the full illuminated volume and thus nanoparticles in dispersion or adhering 332 
externally to the cell membrane are also measured and hence affect the results. Nanoparticle 333 
adhesion to the cell membrane, or in general any surface, can be very strong.
43
 Therefore, an 334 
optimisation of the washing procedure needs to be performed. Figure 4A shows an example of 335 
how to optimise the number of washes to be performed prior to measurement in order to ensure 336 
optimal particle removal.
48
 In this example, after three washes the fluorescence in the washing 337 
buffer becomes much lower suggesting that (in this case) three washes are sufficient to remove 338 
the major part of the remaining particles. Performing additional washes, although they may 339 
further remove residual extracellular nanoparticles, may risk damaging or losing cells prior to 340 
measurement. 341 
To test how large the contribution from nanoparticles adhering externally to cells is, the adhesion 342 
of nanoparticles to the cell membrane can be explicitly measured, as shown for instance in Figure 343 
4B. When cells are cooled to lower temperatures, active nanoparticle uptake processes are 344 
inhibited (as also shown in Figure 3).
43
 This can be used to distinguish the number of internalised 345 
nanoparticles from those adhering externally to cells. In this way it was demonstrated that, 346 
although a small fraction of nanoparticles adhering to the cell membrane may remain even after 347 
careful washes and is in fact measured by flow cytometry, its contribution is almost constant, and 348 
after a few hours of uptake is much smaller compared to the internalised amount. We suggest that 349 
this small residual contamination can be neglected for longer exposure times, assuming continued 350 





Figure 4. Optimisation of the washing procedure and measurement of nanoparticle 354 
adhesion to the outer A549 cell membrane. (A) Fluorescence intensities of the PBS used to 355 
remove extracellular Yellow-Green carboxylated polystyrene nanoparticles of the indicated sizes 356 
adhering to the dish or the outer part of the cell membrane. The results show an optimisation of 357 
the number of washes, with three washes ensuring removal of the majority of the nanoparticles. 358 
Data reproduced from dos Santos et al.
48
 (B) Comparison of the uptake kinetics during 359 
continuous exposure at 37 °C and the adhesion kinetics at 4 °C of 40 nm Yellow-Green 360 
carboxylated polystyrene nanoparticles at 100 μg/ml in complete medium, determined by flow 361 
cytometry. The uptake kinetics during continuous exposure was assessed by exposing cells to 362 
nanoparticles in complete medium at 37 °C for the indicated times; the adhesion kinetics was 363 
assessed by exposing cells to nanoparticles in complete medium at 4 °C for the indicated times, 364 
followed by further incubation for 3 h at 37 °C in nanoparticle-free complete medium, to ensure 365 
that nanoparticles adhering to the outside of the cell membrane had time to enter cells. This is 366 
likely somewhat of an underestimate of the adhering nanoparticles, because some nanoparticles 367 
may desorb during the 3 h of uptake. The mean cell fluorescence of 15,000 cells was determined 368 
for each replica. Data points and error bars represent the mean and standard deviation averaged 369 




Another sensitive step in the preparation of samples for flow cytometry is cell fixation. 372 
Sometimes live cells can be measured, such as when a small number of samples are prepared and 373 
rapidly analysed, or when the cells are robust enough to be kept alive in suspension for some time 374 
prior to measurement. Care should be taken to perform the measurement as quickly as possible 375 
after sample preparation. Often one must, however, use cell fixation to overcome some of these 376 
limits, allowing preparation of a larger number of samples and longer storage times. Moreover, it 377 
allows a better control of the exposure time, since active cellular processes are halted by fixation. 378 
It is important to realise, however, that different fixatives can result in different fluorescence 379 
values being read, even for the same samples. Furthermore, even though fixation halts active 380 
processes, we have observed that especially in the first 1-2 h after cell fixation, fixed cells 381 
undergo strong changes in terms of FS and SS and also in fluorescence intensity. Because of this, 382 
it is recommended to keep the time between fixation and measurement constant for different 383 
samples within the same series. Alternatively, the magnitude of the effect should be determined 384 
explicitly by preparing multiple replicates treated all in the same way and measuring them at 385 
increasing times after fixation. 386 
 387 
2.4. Analysis of flow cytometry results 388 
As shown in Figure 1, flow cytometry allows obtaining cell fluorescence intensity distributions. 389 
Provided that these distributions are relatively narrow and symmetric, and that there are not 390 
multiple or very broad asymmetric peaks, the mean fluorescence intensity can be utilised as a 391 
useful measure of nanoparticle uptake in the studied cell population. It is important to note that in 392 
such cases the cell fluorescence typically converges to the mean value already after a few 393 
thousands of cells have been measured.
7
 In other words, even though flow cytometry allows 394 
measuring very large numbers of cells and obtaining well defined distributions, roughly a few 395 
thousand cells are enough to obtain the mean value for the cell population. This is particularly 396 
interesting when only low numbers of cells are available, for instance when working with 397 
primary cells. 398 
Figure 5 illustrates this in terms of the mean cell fluorescence as a function of the number of cells 399 
measured, in which the number of cells has been artificially limited in the analysis following the 400 
measurement. It may be observed that (in this example) after 3,000-4,000 cells, the mean cell 401 
fluorescence is within 1% of the value measured for the full examined cell population (around 402 
15,000). In other words, measurement of the remaining 11,000-12,000 cells was superfluous, as 403 
far as the mean value is concerned. Of course, in this case the number of cells was only 404 
artificially constrained and we know the “right answer” (assuming the full measured population 405 
of 15,000 cells is an accurate representation). However, for smaller populations, the same 406 
procedure may give some indication of the confidence to be had in the measured mean values. 407 
That is, by calculating how the mean changes with the number of cells, it is possible to at least 408 
get an indication of whether it appears to stabilise. For example, if only 1,500 cells of the 409 
population sampled in Figure 5 had been measured (inset), then it seems obvious that the mean 410 
has not yet stabilised, and more cells need to be measured. Other more formal procedures, e.g., 411 
jackknifing or bootstrapping,
49
 can also give an indication, although the approach described here 412 
is perhaps more visually compelling. 413 
 414 
Figure 5. Mean cell fluorescence of a cell population as a function of the number of cells 415 
analysed. A549 cells were exposed to 25 µg/ml Yellow-Green 40 nm carboxylated polystyrene 416 
nanoparticles for 28 h, and around 15,000 cells from the full population of cells assessed for their 417 
fluorescence by flow cytometry. The mean cell fluorescence was calculated as a function of the 418 
number of cells “measured”, by artificially restricting the number of cells taken into account in 419 
calculating the average. Furthermore, the mean was normalised by the mean of the entire 420 
examined population (~15,000 cells), to show the deviation of the (running) average to the final 421 
average. (Inset) Enlargement of the region up to 1,500 cells. In this case, the mean has been 422 
normalised by the mean calculated for around 1,500 cells, to simulate only having measured this 423 




The fluorescence measured by flow cytometry cannot be (directly) interpreted as absolute 426 
numbers of nanoparticles. Nevertheless, based on the fluorescence of a single nanoparticle 427 
comparative studies of the uptake of nanoparticles of different sizes or different fluorescence 428 
intensity may be performed,
35, 48, 50
 with some accuracy. 429 
Absolute numbers of fluorescent intensities depend on the intensity of the lasers, and the 430 
detectors and their sensitivities, which are not standardised for instruments. This makes direct 431 
comparison of results obtained across different laboratories or with different instruments 432 
challenging. A possible solution is to normalise the data. However, care should be taken when 433 
processing the data in order not to change the outcome. We illustrate this aspect on the data 434 
obtained using the Standard Operating Procedure (SOP) developed within the European Research 435 
Infrastructure QualityNano (included in Supplementary Information), which will be discussed 436 
further below. Figure 6 shows examples of different ways of normalising the data for an 437 
experiment where the same cells were exposed to different doses of the same nanoparticles by 438 
different operators, in different laboratories and using different instruments. The data was 439 
normalised (that is, divided) by the background cell fluorescence and the fluorescence of cells 440 
exposed to the lowest and the highest dose, respectively. We observe that the unnormalised data 441 
(Figure 6A) differ greatly between data series, but nevertheless show a similar trend. Normalising 442 
the data for the background (i.e., presenting the data in terms of “fold increase”) improves the 443 
situation, but only somewhat (Figure 6B). Normalisation to the first data-point where 444 
nanoparticles are present (Figure 6C) makes the data series agree at least over the lower dose 445 
range. An even better agreement is obtained by normalising to the highest dose measured (Figure 446 
6D) which makes the different data series agree to some extent over the whole dose range. The 447 
likely reason is that if there is a relatively constant (with regards to variation in nanoparticle dose) 448 
measurement error, then the data acquired at the highest dose is, on a relative scale, most 449 
trustworthy. Thus using this value to normalise data is least prone to measurement error. 450 
Similarly, using the value at the lowest dose is better than simply the background, where the 451 
latter data is likely least precise. Further improvement may be achieved by assuming a linear 452 
relation (rather than a proportionality, as implicitly assumed when normalising with a constant 453 
factor) between the measured cell fluorescence and the number of nanoparticles. If a good model 454 
for the relation being measured exists, then fitting the data to this model is also a possible way of 455 
“normalising” the data. 456 
 457 
 458 
Figure 6. Data normalisation to allow comparison across different instruments or 459 
laboratories. A549 cells were exposed to different doses of 40 nm Yellow-Green fluorescent 460 
carboxylated polystyrene nanoparticles for 24 h and their fluorescence measured by flow 461 
cytometry by different operators in different laboratories using different instruments. The same 462 
materials were used and the QualityNano SOP for nanoparticle uptake by flow cytometry was 463 
followed. The obtained geometrical mean cell fluorescence intensities are shown here (A) 464 
without any normalisation (raw data in arbitrary units) and after normalisation (that is, division) 465 
by the fluorescence intensities of (B) untreated cells (background) or cells exposed to the (C) 466 
lowest and the (D) highest dose of nanoparticles. Geometrical mean cell fluorescence intensity 467 
values for 15,000 cells/sample were extracted from the obtained cell fluorescence histogram 468 
distributions. Data are the average over 3 replicates and error bars represent the standard 469 
deviation. 470 
 471 
2.5. The QualityNano Standard Operating Procedure for nanoparticle uptake by flow 472 
cytometry and a Round Robin test 473 
Based on the extensive work performed in the different participating laboratories within the 474 
European Research Infrastructure QualityNano, a detailed Standard Operating Procedure (SOP) 475 
was developed to describe in detail how to perform nanoparticle uptake measurements by flow 476 
cytometry, taking into account all of the aspects discussed above. The full SOP is included in the 477 
Supplementary Information. For this SOP, it was decided to use human A549 lung epithelial 478 
carcinoma cells, which are easy to grow and for which SOPs describing cell culture and cell 479 
growth rate determination have also been developed within QualityNano (Nelissen et al., under 480 
review). 481 
The nanoparticles used were Yellow-Green fluorescent carboxylated polystyrene nanoparticles of 482 
40 and 100 nm from commercial sources (Molecular Probes). Extensive work has been 483 
performed with the same nanoparticles and the dispersion and stability in cell culture medium 484 
over time had already been tested.
7
 Thus, they constituted an ideal model nanoparticle of high 485 
quality to allow this kind of study, excluding problems of nanoparticle agglomeration and labile 486 
dye leaching.  487 
The SOP describes each step from cell seeding, nanoparticle dispersion and exposure to cells, up 488 
to sample preparation for flow cytometry, setting of the measurement and methods to report and 489 
analyse the results. The procedure was optimised for the chosen cells, nanoparticles and exposure 490 
times. However, the SOP can easily be adapted to other cells, nanoparticles and conditions, 491 
provided that care is taken in addressing all aspects that can affect these measurements. To this 492 
end, the tests and control experiments described in the previous sections can be used to optimise 493 
the conditions for the tested system and exclude artefacts or quality issues. For instance, for the 494 
chosen nanoparticles, vortexing of the starting stock dispersion prior to and after dilution in cell 495 
culture medium ensures preparation of a homogenous and stable dispersion. Other nanoparticles 496 
may instead require more detailed dispersion protocols. Similarly, for the chosen conditions, the 497 
developed SOP suggests three washes of the cells after exposure to the nanoparticles and uses a 498 
small number of samples. This allows using live cells for the measurements without the need to 499 
perform any fixation. However, this may need to be changed for other nanoparticles or cells. 500 
The SOP was tested in three different laboratories. Each lab received cells, nanoparticles and 501 
serum from a common batch in order to exclude variability due to the use of materials of different 502 
sources. After defrosting cells from liquid nitrogen, experiments were performed in a restricted 503 
range of cell passage numbers, since cell behaviour and growth rate are known to be affected by 504 
passage numbers. Each laboratory performed multiple independent test runs using a dose series 505 
of the nanoparticles. In each run, the variability in nanoparticle preparation was tested by 506 
preparing three independent dispersions in cell culture medium. The percentage of cell debris was 507 
also calculated to monitor potential presence of cell damage and cell death during the preparation 508 
of the samples for measurement. For the same reason, forward/side scattering was also recorded, 509 
as were the fluorescence distributions to ensure that peak shapes were comparable and that 510 
multiple peaks were not detected. 511 
Figure 7 shows the results obtained by the three laboratories in different independent runs. The 512 
mean cell fluorescence values have been normalised by the results for cells exposed to the highest 513 
test doses as suggested above (see Figure 6) in order to allow comparisons. 514 
 515 
Figure 7. Comparison of nanoparticle uptake results obtained with QualityNano SOP 516 
across different laboratories. A549 cells were exposed to different doses of 40 nm (A) and 100 517 
nm (B) Yellow-Green fluorescent carboxylated polystyrene nanoparticles for 24 h and their 518 
fluorescence measured by flow cytometry by different operators in different laboratories using 519 
different instruments. The same materials were used and the QualityNano SOP for nanoparticle 520 
uptake by flow cytometry was followed. The obtained geometrical mean cell fluorescence 521 
intensities were plotted after normalisation (division) by the fluorescence intensities of cells 522 
exposed to the highest dose of nanoparticles. For each sample 15,000 cells were measured and 523 
mean cell fluorescence intensity values were extracted from the obtained cell fluorescence 524 
distributions. Data are the average over 3 replicates and error bars represent the standard 525 
deviation. 526 
The results show a very good level of agreement across the different laboratories, operators and 527 
instruments used, especially for the smaller nanoparticles. A larger variability is observed for 528 
cells exposed to the larger nanoparticles. This may be due to the higher fluorescence per particle 529 
for the larger nanoparticles, which implies that a similar variability on a per particle basis will 530 
lead to a larger variability in cell fluorescence. Another possible cause includes a stronger 531 
adhesion to the cell membrane for the larger nanoparticles,
43
 which implies that the detailed 532 
nature of the washing steps performed prior to measurements may matter more and lead to a 533 
larger variability when performed in different laboratories. 534 
In general, though, these results clearly show that this SOP allows obtaining highly reproducible 535 
results in independent laboratories. It is important also to stress that while the SOP presented here 536 
was developed specifically for measuring uptake of a set of polystyrene nanoparticles, the 537 
approaches presented and experiments suggested to optimize each step of the procedure can be 538 
easily adapted for other cells and nanoparticles. Indeed similar results have also been obtained for 539 
instance for cells exposed to silica nanoparticles,
35,44
 confirming that the method is well suited 540 
also to study uptake of other materials. 541 
 542 
3. Conclusions 543 
Flow cytometry is a technique widely available in life science laboratories, which allows 544 
measuring uptake of fluorescent nanoparticles in individual cells and generates high quality high 545 
content data with ease. Even though it does not measure absolute nanoparticle numbers in cells, it 546 
presents several advantages with respect to other methods currently available for nanoparticle 547 
uptake quantification.  548 
Several aspects which have been reported and summarised here need to be taken into account 549 
when performing flow cytometry measurements with nanoparticles in order to exclude potential 550 
errors and artefacts related to the nature of nanoparticles and their properties.  Provided these are 551 
taken into account, flow cytometry is a robust method to generate high quality data of 552 
nanoparticle uptake into cells. 553 
A robust SOP was developed and optimised within the Research Infrastructure QualityNano 554 
based on the knowledge gained in the past years with this method. This SOP allows assessing 555 
nanoparticle uptake by cells with very good agreement between different independent 556 
laboratories and with different instruments. The same method and approaches can be easily used 557 
to implement similar SOPs for other cells, nanoparticles and conditions and measure nanoparticle 558 
uptake by flow cytometry. 559 
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